BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25475893)

  • 1. Sequential control of biosynthetic pathways for balanced utilization of metabolic intermediates in Saccharomyces cerevisiae.
    Xie W; Ye L; Lv X; Xu H; Yu H
    Metab Eng; 2015 Mar; 28():8-18. PubMed ID: 25475893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significantly Enhanced Production of Patchoulol in Metabolically Engineered
    Ma B; Liu M; Li ZH; Tao X; Wei DZ; Wang FQ
    J Agric Food Chem; 2019 Aug; 67(31):8590-8598. PubMed ID: 31287301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A squalene synthase protein degradation method for improved sesquiterpene production in Saccharomyces cerevisiae.
    Peng B; Plan MR; Chrysanthopoulos P; Hodson MP; Nielsen LK; Vickers CE
    Metab Eng; 2017 Jan; 39():209-219. PubMed ID: 27939849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a growth-phase-dependent biosynthetic pathway for carotenoid production in Saccharomyces cerevisiae.
    Su B; Song D; Yang F; Zhu H
    J Ind Microbiol Biotechnol; 2020 May; 47(4-5):383-393. PubMed ID: 32236768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Saccharomyces cerevisiae for geranylgeraniol overproduction by combinatorial design.
    Song TQ; Ding MZ; Zhai F; Liu D; Liu H; Xiao WH; Yuan YJ
    Sci Rep; 2017 Nov; 7(1):14991. PubMed ID: 29118396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of farnesyl diphosphate pool as direct precursor of sesquiterpenes through metabolic engineering of the mevalonate pathway in Saccharomyces cerevisiae.
    Asadollahi MA; Maury J; Schalk M; Clark A; Nielsen J
    Biotechnol Bioeng; 2010 May; 106(1):86-96. PubMed ID: 20091767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial acetyl-CoA utilization pathway for terpenoid productions.
    Yuan J; Ching CB
    Metab Eng; 2016 Nov; 38():303-309. PubMed ID: 27471067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycopene overproduction in Saccharomyces cerevisiae through combining pathway engineering with host engineering.
    Chen Y; Xiao W; Wang Y; Liu H; Li X; Yuan Y
    Microb Cell Fact; 2016 Jun; 15(1):113. PubMed ID: 27329233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of the sesquiterpene (+)-valencene by metabolically engineered Corynebacterium glutamicum.
    Frohwitter J; Heider SA; Peters-Wendisch P; Beekwilder J; Wendisch VF
    J Biotechnol; 2014 Dec; 191():205-13. PubMed ID: 24910970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of lycopene-overproducing Saccharomyces cerevisiae by combining directed evolution and metabolic engineering.
    Xie W; Lv X; Ye L; Zhou P; Yu H
    Metab Eng; 2015 Jul; 30():69-78. PubMed ID: 25959020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined metabolic engineering of precursor and co-factor supply to increase α-santalene production by Saccharomyces cerevisiae.
    Scalcinati G; Partow S; Siewers V; Schalk M; Daviet L; Nielsen J
    Microb Cell Fact; 2012 Aug; 11():117. PubMed ID: 22938570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-Terpineol production from an engineered Saccharomyces cerevisiae cell factory.
    Zhang C; Li M; Zhao GR; Lu W
    Microb Cell Fact; 2019 Sep; 18(1):160. PubMed ID: 31547812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affibody Scaffolds Improve Sesquiterpene Production in Saccharomyces cerevisiae.
    Tippmann S; Anfelt J; David F; Rand JM; Siewers V; Uhlén M; Nielsen J; Hudson EP
    ACS Synth Biol; 2017 Jan; 6(1):19-28. PubMed ID: 27560952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase.
    Paradise EM; Kirby J; Chan R; Keasling JD
    Biotechnol Bioeng; 2008 Jun; 100(2):371-8. PubMed ID: 18175359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic engineering of Saccharomyces cerevisiae for production of germacrene A, a precursor of beta-elemene.
    Hu Y; Zhou YJ; Bao J; Huang L; Nielsen J; Krivoruchko A
    J Ind Microbiol Biotechnol; 2017 Jul; 44(7):1065-1072. PubMed ID: 28547322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the intracellular isoprenoid pool in Saccharomyces cerevisiae by structural fine-tuning of a bifunctional farnesyl diphosphate synthase.
    Rubat S; Varas I; Sepúlveda R; Almonacid D; González-Nilo F; Agosin E
    FEMS Yeast Res; 2017 Jun; 17(4):. PubMed ID: 28854674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Evolution and Metabolic Engineering Boost Lycopene Production in
    Zhou K; Yu C; Liang N; Xiao W; Wang Y; Yao M; Yuan Y
    J Agric Food Chem; 2023 Mar; 71(8):3821-3831. PubMed ID: 36802623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae.
    Dai Z; Liu Y; Huang L; Zhang X
    Biotechnol Bioeng; 2012 Nov; 109(11):2845-53. PubMed ID: 22566191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous biosynthesis and manipulation of crocetin in Saccharomyces cerevisiae.
    Chai F; Wang Y; Mei X; Yao M; Chen Y; Liu H; Xiao W; Yuan Y
    Microb Cell Fact; 2017 Mar; 16(1):54. PubMed ID: 28356104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Nonnatural C
    Li L; Furubayashi M; Hosoi T; Seki T; Otani Y; Kawai-Noma S; Saito K; Umeno D
    ACS Synth Biol; 2019 Mar; 8(3):511-520. PubMed ID: 30689939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.